臨床試験

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

NCT: NCT05794880 · RECRUITING

NCT識別子NCT05794880

ステータスRECRUITING

開始日2023-05-01

SponsorMedical College of Wisconsin (OTHER)

First posted2023-04-03

Last updated2026-05-13

概要

This is a single arm pilot study for patients with hematologic malignancies receiving unrelated or haploidentical related mobilized peripheral stem cells (PSCs) using the CliniMACS system for alpha/beta T cell depletion plus CD19+ B cell depletion with individualized ALC-based dosing of ATG to study impact on engraftment, GVHD, and disease free survival

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。